ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia.
Blood Cancer Journal
Menezes, J J; Salgado, R N RN; Acquadro, F F; Gómez-López, G G; Carralero, M C MC; Barroso, A A; Mercadillo, F F; Espinosa-Hevia, L L; Talavera-Casañas, J G JG; Pisano, D G DG; Alvarez, S S; Cigudosa, J C JC